Holen Sie sich die Stockscreener-App
44.73
0.38%
0.17
Schlusskurs vom Vortag:
$44.56
Offen:
$44.18
24-Stunden-Volumen:
1.51M
Relative Volume:
1.01
Marktkapitalisierung:
$4.91B
Einnahmen:
$9.49B
Nettoeinkommen (Verlust:
$-1.06B
KGV:
-4.4736
EPS:
-9.9986
Netto-Cashflow:
$878.00M
1W Leistung:
-0.27%
1M Leistung:
-2.95%
6M Leistung:
-34.43%
1J Leistung:
+11.38%
1-Tages-Spanne:
$43.60
$44.81
1-Wochen-Bereich:
$43.59
$46.03
52-Wochen-Spanne:
$35.13
$70.70
Celanese Corp Stock (CE) Company Profile
Firmenname
Celanese Corp
Sektor
Branche
Telefon
972-443-4000
Adresse
222 W. LAS COLINAS BLVD., SUITE 900N, IRVING, TX
Compare CE vs DOW, MEOH, OLN, HUN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CE
Celanese Corp
|
44.73 | 4.91B | 9.49B | -1.06B | 878.00M | -9.9986 |
DOW
Dow Inc
|
28.51 | 20.59B | 39.33B | -2.61B | -232.00M | -3.9914 |
MEOH
Methanex Corp
|
63.12 | 4.88B | 3.67B | 16.39M | 550.63M | -0.466 |
OLN
Olin Corp
|
14.87 | 1.69B | 6.72B | -127.60M | 272.00M | -1.1213 |
HUN
Huntsman Corp
|
8.16 | 1.43B | 5.69B | -270.00M | 135.00M | -1.8695 |
Celanese Corp Stock (CE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2026-05-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2026-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-03-09 | Hochstufung | Tudor, Pickering, Holt & Co. | Hold → Buy |
| 2026-03-09 | Hochstufung | Vertical Research | Hold → Buy |
| 2026-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2026-01-20 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-05-20 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2025-03-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-17 | Hochstufung | Alembic Global Advisors | Neutral → Overweight |
| 2025-03-06 | Hochstufung | Vertical Research | Sell → Hold |
| 2025-02-20 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-11-11 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2024-11-11 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-08 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-11-06 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-29 | Herabstufung | Vertical Research | Hold → Sell |
| 2024-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-09-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-08-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-04 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-02-26 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-02-22 | Herabstufung | Tudor, Pickering, Holt & Co. | Buy → Sell |
| 2024-01-22 | Herabstufung | Alembic Global Advisors | Overweight → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-11-21 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-09-06 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-08-29 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2023-08-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-06-26 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-14 | Eingeleitet | Citigroup | Neutral |
| 2023-06-09 | Herabstufung | Vertical Research | Buy → Hold |
| 2023-04-12 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-03-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-10-11 | Eingeleitet | Mizuho | Neutral |
| 2022-08-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-07-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-27 | Eingeleitet | Credit Suisse | Underperform |
| 2022-02-22 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-11-22 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-11-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Hochstufung | Vertical Research | Hold → Buy |
| 2021-07-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-09 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-05 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-12-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-11-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-10-27 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-10-27 | Herabstufung | Vertical Research | Buy → Hold |
| 2020-10-07 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-22 | Eingeleitet | Evercore ISI | Outperform |
| 2020-07-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-07-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-27 | Hochstufung | Alembic Global Advisors | Neutral → Overweight |
| 2020-05-29 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-04-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-03-30 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-26 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-03-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-03-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2020-02-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2020-01-07 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Celanese Corp Aktie (CE) Neueste Nachrichten
APD Gains on Growth Project and Productivity Amid Helium Pricing Woes - Zacks Investment Research
DuPont Expands Sugar Separation Expertise With New Digital Tool - Zacks Investment Research
Celanese (NYSE:CE) Stock Forecast & Analyst Predictions - Simply Wall Street
Celanese: Some Stabilization In A Still-Uncertain Story (NYSE:CE) - Seeking Alpha
Celanese Corporation stock at USD 46.55 on September 28, 2026 - AD HOC NEWS
Celanese stock gains after board move and steady guidance - AD HOC NEWS
KeyBanc initiates Celanese stock coverage with overweight rating By Investing.com - Investing.com Nigeria
KeyBanc initiates Celanese stock coverage with overweight rating By Investing.com - Investing.com South Africa
KeyBanc initiates Celanese stock coverage with overweight rating By Investing.com - Investing.com Canada
KeyBanc initiates Celanese stock coverage with overweight rating By Investing.com - Investing.com UK
KeyBanc initiates Celanese stock coverage with overweight rating - Investing.com
Celanese stock heads into the open after a 0.8 percent gain - ad-hoc-news.de
Celanese Corp. stock outperforms competitors on strong trading day - MarketWatch
Celanese Corporation (CE) is Selling Another 19% of Nutrinova for $152 Million. Is Deleveraging Worth Reducing Its Stake to 11%? - Yahoo Finance
Celanese options flow: a calendar spread targets the Oct 2026 window - Investing.com
Celanese stock heads into the open after a 0.3% dip - ad-hoc-news.de
Celanese Corp. stock edges lower after Q2 2026 earnings and Nutrinova stake sale - ad-hoc-news.de
Celanese Corp. stock gains in premarket as investors weigh recent earnings and outlook - ad-hoc-news.de
Celanese Corp. stock holds steady as guidance and fund flows shape outlook - ad-hoc-news.de
ETFs Investing in Celanese Corporation Stocks - tradingview.com
Celanese Corp. stock outperforms competitors despite losses on the day - MarketWatch
CE Stock Price and Chart — NYSE:CE - TradingView
Celanese Corp. stock edges lower as investors digest Q2 2026 earnings beat - AD HOC NEWS
Celanese Corp (CE) Stock Down 3.1% -- Now Undervalued? GF Score: 71/100 - GuruFocus
Celanese Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Why Is Celanese (CE) Up 8.2% Since Last Earnings Report? - Yahoo Finance
Celanese Corp. stock gains as Nutrinova stake sale reshapes portfolio - ad-hoc-news.de
Celanese Corp (CE) Shares Surge 5.7% -- What GF Score of 67 Tells Investors - GuruFocus
Celanese Corp. stock outperforms competitors on strong trading day - MarketWatch
Celanese Corp. stock reacts to Nutrinova stake sale and JV reshaping - ad-hoc-news.de
Celanese to sell 19% Nutrinova stake to Mitsui for $152 million - Indian Chemical News
Celanese Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Sudarshan Chemical Sells VP4 Frankfurt Subsidiary to Celanese in Strategic Pigments Focus MoveBuyback Announcement Report - dars.gov.et
Celanese to Sell Additional 19% of Nutrinova Stake to Mitsui for $152M - Yahoo Finance
Sudarshan Chemical sells VP4 Frankfurt to Celanese to double down on pigments - Indian Chemical News
CE Looks 29.1% Undervalued on GF Value™ Amidst Nutrinova Stake S - GuruFocus
Celanese Corp. stock outperforms competitors on strong trading day - MarketWatch
Celanese to Sell Additional 19% Nutrinova Stake to Mitsui for $152 Million - marketscreener.com
Sudarshan Chemical sells VP4 Frankfurt stake to Celanese for EUR 76.5 million - scanx.trade
Celanese to Sell Additional Shares of Nutrinova Joint Venture to Mitsui & Co., Ltd. - Yahoo Finance
Celanese stock holds below recent highs as institutional buying supports the shares - ad-hoc-news.de
Mitsui & Co., Ltd. agreed to acquire an additional 19% stake in Nutrinova Netherlands B.V. from Celanese Corporation (NYSE:CE) for $152 million. - marketscreener.com
Celanese stock holds steady after strong Q2 2026 earnings progress - ad-hoc-news.de
Celanese stock holds steady as Q2 revenue tops $2.75 billion - AD HOC NEWS
Celanese stock holds steady as Q3 2026 earnings estimates rise - ad-hoc-news.de
Alembic Global Maintains Celanese Corp(CE.US) With Buy Rating, Cuts Target Price to $65 - Moomoo
Celanese stock gains on a $4.97 billion market cap and Q2 beat - ad-hoc-news.de
Celanese Corp (CE) Stock Down 3.3% -- Now Undervalued? GF Score: 71/100 - GuruFocus
Celanese CFO Chuck Kyrish Buys 2,300 Shares for $105,000. What Is This Telling Investors? - Yahoo Finance
Madison Asset Management LLC Makes New Investment in Celanese Corporation $CE - MarketBeat
Finanzdaten der Celanese Corp-Aktie (CE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celanese Corp-Aktie (CE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Duffie Ashley B | SVP & GC |
Aug 11 '26 |
Buy |
45.60 |
600 |
27,360 |
31,925 |
| Murray Mark Christopher | SVP - Acetyls |
Aug 11 '26 |
Buy |
45.52 |
2,153 |
98,004 |
30,432 |
| Richardson Scott A | CEO & President |
Dec 10 '25 |
Buy |
41.59 |
3,800 |
158,042 |
70,449 |
| Kyrish Chuck | SVP & CFO |
Dec 09 '25 |
Buy |
41.03 |
5,000 |
205,150 |
10,914 |
2.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):